555 related articles for article (PubMed ID: 6351756)
1. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
Anhalt GJ; Patel H; Diaz LA
Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
[No Abstract] [Full Text] [Related]
2. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].
Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636
[No Abstract] [Full Text] [Related]
3. Bullous pemphigoid and pemphigus vulgaris.
Patel HP; Anhalt GJ; Diaz LA
Ann Allergy; 1983 Mar; 50(3):144-50. PubMed ID: 6338766
[No Abstract] [Full Text] [Related]
4. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
Brooks WS; Lee YY; Abell E; Deng JS
J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
[TBL] [Abstract][Full Text] [Related]
5. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
Stanley JR
J Clin Invest; 1989 May; 83(5):1443-8. PubMed ID: 2651476
[No Abstract] [Full Text] [Related]
6. Immunopathology of pemphigus vulgaris, bullous pemphigoid and related bullous dermatoses.
Patel HP; Anhalt GJ; Provost TT; Diaz LA
Clin Immunol Rev; 1983-1984; 2(2):157-86. PubMed ID: 6370527
[No Abstract] [Full Text] [Related]
7. Immunopathologic mechanisms in pemphigus and bullous pemphigoid.
Jordon RE; Kawana S; Fritz KA
J Invest Dermatol; 1985 Jul; 85(1 Suppl):72s-78s. PubMed ID: 3891883
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis of bullous pemphigoid in the light of modern immunologic knowledge].
Remy W
Fortschr Med; 1977 Nov; 95(42):2553-8. PubMed ID: 334658
[No Abstract] [Full Text] [Related]
9. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.
Toosi S; Bystryn JC
Med Hypotheses; 2010 Apr; 74(4):727-8. PubMed ID: 19945799
[TBL] [Abstract][Full Text] [Related]
10. [On the autoimmune pathogenesis of bullous pemphigoid. Review of the literature and our results (author's transl)].
Haustein UF; Lohrisch I; Herrmann K
Dermatol Monatsschr; 1980 Sep; 166(9):585-98. PubMed ID: 7004925
[No Abstract] [Full Text] [Related]
11. Immunohistochemical study on 70 human embryos concerning the epidermal binding of pemphigus and pemphigoid antibodies.
Varelzidis A; Tosca A; Coumantakis E; Nicolis G; Hatzis J; Papavasiliou S; Stratigos J
Acta Derm Venereol; 1980; 60(2):129-33. PubMed ID: 6155018
[TBL] [Abstract][Full Text] [Related]
12. A functional assay for complement-activating antibodies to the cutaneous basement membrane zone.
Gammon WR; Merritt CC
Ann N Y Acad Sci; 1983; 420():335-42. PubMed ID: 6372599
[No Abstract] [Full Text] [Related]
13. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
14. Immunopathological techniques in the diagnosis of bullous disorders.
Black MM; Bhogal BS; Willsteed E
Acta Derm Venereol Suppl (Stockh); 1989; 151():96-105; discussion 106-10. PubMed ID: 2696314
[TBL] [Abstract][Full Text] [Related]
15. In vitro organ culture model for mucous membrane pemphigoid.
Colón JE; Bhol KC; Razzaque MS; Ahmed AR
Clin Immunol; 2001 Feb; 98(2):229-34. PubMed ID: 11161979
[TBL] [Abstract][Full Text] [Related]
16. [Application of the biotin-avidin system to the study of autoimmune bullous diseases: immunofluorescence method using biotinylated-pemphigus and -pemphigoid antibodies and fluoresceinated avidin].
Muramatsu T; Sakamoto K; Ikeda S
Nihon Hifuka Gakkai Zasshi; 1988 Sep; 98(10):977-80. PubMed ID: 3065537
[No Abstract] [Full Text] [Related]
17. Detection of autoantibodies in autoimmune bullous skin diseases: can we do better?
Baum S; Zafrir Y; Barzilai A
Isr Med Assoc J; 2014 Apr; 16(4):244-5. PubMed ID: 24834762
[No Abstract] [Full Text] [Related]
18. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
Dainichi T; Chow Z; Kabashima K
J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
[TBL] [Abstract][Full Text] [Related]
19. Molecular biological aspects of acquired bullous diseases.
Dabelsteen E
Crit Rev Oral Biol Med; 1998; 9(2):162-78. PubMed ID: 9603234
[TBL] [Abstract][Full Text] [Related]
20. The distribution of IgG subclasses in pemphigoid gestationis: PG factor is an IgG1 autoantibody.
Kelly SE; Cerio R; Bhogal BS; Black MM
J Invest Dermatol; 1989 May; 92(5):695-8. PubMed ID: 2654296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
